1. Home
  2. DSS vs AIMD Comparison

DSS vs AIMD Comparison

Compare DSS & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DSS

DSS Inc.

HOLD

Current Price

$0.56

Market Cap

5.3M

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.89

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
AIMD
Founded
1984
1984
Country
United States
United States
Employees
N/A
41
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
17.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DSS
AIMD
Price
$0.56
$1.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.8M
887.7K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
42.45
N/A
EPS
N/A
N/A
Revenue
$2,085,000.00
N/A
Revenue This Year
$1.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$0.45
52 Week High
$1.90
$4.50

Technical Indicators

Market Signals
Indicator
DSS
AIMD
Relative Strength Index (RSI) 50.68 48.27
Support Level $0.36 $1.83
Resistance Level $1.05 $2.51
Average True Range (ATR) 0.13 0.29
MACD 0.02 -0.05
Stochastic Oscillator 28.40 11.22

Price Performance

Historical Comparison
DSS
AIMD

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: